Location: Montreal, Quebec
Industry: Life Sciences
Company Overview: Nanogenecs is building a convenient and inexpensive medical diagnostic portable platform that measures your blood chemistry in a matter of minutes to deliver actionable insights. Such insights will improve the management of chronic diseases, bringing the safeguard high-quality laboratory testing at home.
Our Story: Ripple met the founder and CEO of Nanogenecs, Shahid Azim in Sept 2017 in Boston and was immediately attracted to the high quality team surrounding this venture. With high profile industry executives helping take the Nanogenecs technology from lab to market, Ripple decided to lead the angel investment round in the company.